Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
INTRODUCTION: It is very common that migraine patients could refer neck pain during or after the pain phase of migraine, suggesting that migraine pathophysiological mechanisms could be effective in activating neck pain pathways and be part of the migraine attack. Due to the therapeutic effect of multimodal physical therapy (mobilization and/or manipulation plus exercises) on several pain conditions arising from articular and/or muscular structures such as neck pain, and given the close clinical, anatomical and pathogenetic bi-directional relationship between neck pain and migraine, it would be of interest to evaluate the effectiveness of the physical treatment of the neck region in migraine pain.
PURPOSE: to evaluate the efficacy of a combined multimodal physical therapy approach plus usual care vs. usual care alone in subjects with episodic and chronic migraine with concomitant cervical musculoskeletal dysfunctions.
STUDY DESIGN: this is a prospective, parallel group, randomized clinical trial. METHODS: A total of 56 subjects aged 18-65 who meet criteria for episodic or chronic migraine with concomitant cervical musculoskeletal dysfunctions will be randomly assigned to receive, musculoskeletal focused multimodal physical therapy (16 sessions over 8 weeks) plus usual care treatment vs. usual care alone.
CONFLICT OF INTEREST: not declared.
Study design This is a prospective, parallel group, randomized clinical trial evaluating multimodal care plus usual care vs. usual care alone in episodic and chronic migraine with concomitant muscoloskeletal dysfunctions.
The total study duration from the Screening Visit to the Completion Visit is approximately 28 weeks and includes a Screening Period (12 weeks) and an intervention period (8 weeks) followed by an observational period post treatment (8 weeks) for each participant.
Procedures Eligible patients who provided informed consent started the screening period of 12 weeks to confirm migraine frequency, stable prophylactic migraine treatment, including and inclusion/exclusion criteria. During the screening period patients collected informations including number of monthly migraine days, use of acute medication, migraine days with use of acute medication, headache severity (graded as mild, moderate or severe) and duration by using daily migraine report. Migraine associate disability (MIDAS), neck associated disability (NDI) and level of depression (PHQ-9) were detected by using appropriate tests at the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28). During the screening period each participant underwent a physical examination test by physical therapists (LDA, FL, MS) specialized in manual therapy to detect cervical musculoskeletal dysfunctions, including temporomandibular disorders, which are potentially tractable with physical therapy. Physical examination assessed cervicothoracic spine posture, ranges of motion, presence of myofascial trigger points, cervical and temporo-mandibular joint movement restriction.
Procedures Participants who have completed the screening period will be randomized 1:1, using an automatic allocation system, to receive multimodal physical therapy treatment in addition to standard pharmacological treatment or standard pharmacological treatment alone (usual care). The sample will be stratified according to the diagnosis of headache (episodic migraine or chronic migraine), cervical and / or temporomandibular musculoskeletal dysfunction and concomitant myofascial disorder. After 8 weeks of treatment, participants will be monitored for a follow-up phase free of physical treatment lasting an additional 8 weeks.
A research assistant in the study (NM) will monitor the blinding of the study and assign the participants to the intervention.
The physical therapist and the neurologist will be blinded each other in relation to the diagnosis of headache and the type physical therapy treatment that will be practiced on the patient.
Examination procedures
Functional evaluation of the cervical spine
Imaging and provocative maneuvers
Interventions All visits and treatments will take place at the Headaches Medicine Unit of IRCSS Neuromed in Pozzilli (IS) and the study participants will be treated by three physical therapists: LD, MS, FL. All appointments by date and time will be recorded to monitor participants adherence to the treatment. The details of each individual treatment session, including any adverse effects related to the treatment, will be systematically recorded in the patient's medical record. Adverse events include: worsening of headache and / or neck pain and / or reduction of cervical joint ROM or any other health and safety event in relation to treatment.
The neurological and physical medicine examination, combined with the physical therapy evaluation, will include the complete history of the headache, evaluation of the risk factors that may indicate contraindication to the treatment, clinical history of the patient with particular focus on lifestyle habits and incorrect attitudes / postures that may promote musculoskeletal disorders and therefore pain, neck tension and headache.
Patients will receive a cycle of 16 sessions of multimodal physical therapy treatment in 8 weeks, followed by an 8-week suspension phase of the rehabilitation treatment. The first session and subsequent sessions including physical assessments (T1-T2) will have a duration of 50 minutes, all other sessions will have a duration of 30 minutes.
Multimodal physical therapy approach group
All these interventions will be shown and performed with the aim of improving the patient's self-efficacy in self-management of symptoms. The hypothesis is that manipulative manual therapy, combined with therapeutic exercise, may have a hypoalgesic effect in patients affects from migraine .
• Temporomandibular joint treatment: Treatment techniques consist of accessory (translational) movements of the temporomandibular region and / or techniques for the masticatory muscles, such as trigger point treatment and muscle stretching.
Statistical Analysis The calculation of the sample size was based on an effect size d = 0.5, 80% of the sample power and Bonferroni correction of the alpha to 0.05 for the main variable represented by the number of headache days per month. The total number of the sample was found to be 56 (28 subjects per group).
The differences between the data relating to the two groups of experimental and usual care treatment will be performed using ANOVA for repeated measures with Bonferroni correction p-value 0.05 for continuous variables and Kruskal-Wallis Test with correction by Dunn's Test for ordinal variables.
Risk of multimodal physical therapy approach
The risks of serious adverse events related to the multimodal physical therapy approach, including neurological and cerebrovascular diseases, are considered very low, however their exact incidence is unknown. Estimates range from 1 in 200,000 to 1 in several million cervical spine manipulations. Minor adverse events such as neck pain, stiffness, fatigue and headache are much more common in clinical practice. All participants were given instructions at the start of the study to report any adverse event (AE) to study staff within 24 hours. Safety measures included the occurrence of spontaneously reported treatment emergent adverse events.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Multimodal Physical therapy approach plus usual care | Active Comparator | HVLA spinal manipulation, mobilization, soft tissue treatment, therapeutic exercise, education, plus standard pharmacological treatment. |
|
| Usual care | No Intervention | Standard pharmacological treatment alone |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Multimodal Physical therapy approach plus usual care | Procedure | HVLA spinal manipulation, mobilization, soft tissue treatment, therapeutic exercise, education, plus standard pharmacological treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in screening period monthly migraine days at the end of the intervention period (week 20) and at the end of the study (week 28) (daily migraine report) | Number of monthly migraine days | At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28) |
| Change in screening period monthly migraine days with use of acute medication at the end of the intervention period (week 20) and at the end of the study (week 28) (daily migraine report) | Monthly migraine days with use of acute medication | At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in screening period Migraine Disability Assessment Score (MIDAS) at the end of the intervention period (week 20) and at the end of the study (week 28) | Migraine disability assessment score (MIDAS) The scale ranges between 0 "little or no disability" and 5 "severe disability" | At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28) |
Not provided
Inclusion criteria
Exclusion criteria
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Armando Perrotta, MD | Contact | 3394007593 | +39 | arm.perrotta@gmail.com |
| Luciano D'Ambrosio, PT | Contact | 3282292254 | +39 | luciano.dambrosio89@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Armando Perrotta, MD | Neuromed IRCCS | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IRCCS Neuromed | Recruiting | Pozzilli | Isernia | 86077 | Italy |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29368949 | Background | Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available. | |
| 24853166 | Background | Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia. 2015 Mar;35(3):211-9. doi: 10.1177/0333102414535110. Epub 2014 May 22. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| D007592 | Joint Diseases |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Prospective, parallel group, randomized clinical trial.
Not provided
Not provided
Physiotherapists are blinded toward the diagnosis and outcome measures.
|
| Usual care | Drug | Standard pharmacological treatment alone. |
|
|
| Change in screening period Neck disability index (NDI) at the end of the intervention period (week 20) and at the end of the study (week 28) | Neck disability index (NDI) Each of the 10 items is scored from 0 - 5. The score between 0 and 4 indicates "no disability", the score above 34 indicates a severe disability | At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28) |
| Change in screening period Patient Health Questionnaire-9 (PHQ-9) at the end of the intervention period (week 20) and at the end of the study (week 28) | Patient Health Questionnaire-9 (PHQ-9) The score between 0 and 4 indicates "none depression", the maximum score between 20 and 27 indicates a severe depression | At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28) |
| 24863346 | Background | Florencio LL, Chaves TC, Carvalho GF, Goncalves MC, Casimiro EC, Dach F, Bigal ME, Bevilaqua-Grossi D. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study. Headache. 2014 Jul-Aug;54(7):1203-10. doi: 10.1111/head.12393. Epub 2014 May 26. |
| 28641450 | Background | Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia. 2018 Apr;38(5):865-875. doi: 10.1177/0333102417716934. Epub 2017 Jun 22. |
| 12946290 | Background | Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep. 2003 Oct;7(5):371-6. doi: 10.1007/s11916-003-0036-y. |
| D009422 | Nervous System Diseases |
| D009140 | Musculoskeletal Diseases |